Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial
Abstract Objectives The effect of rupatadine, a novel H1 antihistamine with platelet‐activating factor antagonist activity, had been demonstrated for itching in Japanese patients with chronic spontaneous urticaria, dermatitis, or pruritus in a 12‐month, open‐label clinical trial (JapicCTI‐152787). H...
Main Authors: | Michihiro Hide, Takamasa Suzuki, Ayaka Tanaka, Hiroshi Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Journal of Cutaneous Immunology and Allergy |
Subjects: | |
Online Access: | https://doi.org/10.1002/cia2.12072 |
Similar Items
-
Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients
by: Abhishek De, et al.
Published: (2021-01-01) -
Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study
by: Esther Serra, et al.
Published: (2020-04-01) -
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
by: Staevska MT
Published: (2016-11-01) -
Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial
by: Ganesh N Dakhale, et al.
Published: (2016-01-01) -
The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
by: A. A. Kubanov, et al.
Published: (2017-08-01)